Rigel Pharmaceuticals | Utile Per Azione





Eps Cambiamento Data
Agenus USD -1.03 1.01 2025-03
Amgen USD 5.29 0.35 2025-12
Anika Therapeutics USD -0.34 1.16 2025-03
Arrowhead Research USD 0.22 0.33 2025-12
AstraZeneca USD 2.12 0.26 2025-12
BioMarin Pharmaceutical USD 0.12 1.32 2025-09
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Celldex Therapeutics USD -1.01 0.16 2025-09
Daiichi Sankyo JPY 46.79 22.27 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Halozyme Therapeutics USD 1.72 0.18 2025-09
Heron Therapeutics USD -0.03 0.03 2024-09
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.8 1.5 2025-09
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 3.09 1.49 2025-09
MacroGenics USD 0.27 0.84 2025-09
Neurocrine Biosciences USD 2.17 0.52 2025-09
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Ultragenyx Pharmaceutical USD -1.81 0.64 2025-09
Veracyte USD 0.51 0.07 2025-09


Rigel Pharmaceuticals Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.